SOPHiA GENETICS Statistics
Total Valuation
SOPHiA GENETICS has a market cap or net worth of $292.42 million. The enterprise value is $274.18 million.
Important Dates
The last earnings date was Tuesday, November 4, 2025, before market open.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SOPHiA GENETICS has 67.85 million shares outstanding. The number of shares has increased by 2.21% in one year.
| Current Share Class | 67.85M |
| Shares Outstanding | 67.85M |
| Shares Change (YoY) | +2.21% |
| Shares Change (QoQ) | +0.69% |
| Owned by Insiders (%) | 6.43% |
| Owned by Institutions (%) | 31.00% |
| Float | 50.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.95 |
| Forward PS | 3.40 |
| PB Ratio | 4.82 |
| P/TBV Ratio | 11.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.80, with a Debt / Equity ratio of 1.04.
| Current Ratio | 2.80 |
| Quick Ratio | 2.44 |
| Debt / Equity | 1.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -19.61 |
Financial Efficiency
Return on equity (ROE) is -86.09% and return on invested capital (ROIC) is -32.42%.
| Return on Equity (ROE) | -86.09% |
| Return on Assets (ROA) | -25.59% |
| Return on Invested Capital (ROIC) | -32.42% |
| Return on Capital Employed (ROCE) | -55.19% |
| Revenue Per Employee | $173,279 |
| Profits Per Employee | -$177,253 |
| Employee Count | 423 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 3.62 |
Taxes
In the past 12 months, SOPHiA GENETICS has paid $2.52 million in taxes.
| Income Tax | 2.52M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +18.08% in the last 52 weeks. The beta is 1.11, so SOPHiA GENETICS's price volatility has been higher than the market average.
| Beta (5Y) | 1.11 |
| 52-Week Price Change | +18.08% |
| 50-Day Moving Average | 4.12 |
| 200-Day Moving Average | 3.47 |
| Relative Strength Index (RSI) | 48.58 |
| Average Volume (20 Days) | 121,992 |
Short Selling Information
The latest short interest is 137,679, so 0.20% of the outstanding shares have been sold short.
| Short Interest | 137,679 |
| Short Previous Month | 21,773 |
| Short % of Shares Out | 0.20% |
| Short % of Float | 0.27% |
| Short Ratio (days to cover) | 1.00 |
Income Statement
In the last 12 months, SOPHiA GENETICS had revenue of $73.30 million and -$74.98 million in losses. Loss per share was -$1.12.
| Revenue | 73.30M |
| Gross Profit | 49.49M |
| Operating Income | -69.83M |
| Pretax Income | -72.46M |
| Net Income | -74.98M |
| EBITDA | -68.58M |
| EBIT | -69.83M |
| Loss Per Share | -$1.12 |
Full Income StatementBalance Sheet
The company has $81.61 million in cash and $63.37 million in debt, giving a net cash position of $18.24 million or $0.27 per share.
| Cash & Cash Equivalents | 81.61M |
| Total Debt | 63.37M |
| Net Cash | 18.24M |
| Net Cash Per Share | $0.27 |
| Equity (Book Value) | 60.69M |
| Book Value Per Share | 0.89 |
| Working Capital | 66.55M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$36.75 million and capital expenditures -$293,000, giving a free cash flow of -$37.04 million.
| Operating Cash Flow | -36.75M |
| Capital Expenditures | -293,000 |
| Free Cash Flow | -37.04M |
| FCF Per Share | -$0.55 |
Full Cash Flow StatementMargins
Gross margin is 67.52%, with operating and profit margins of -95.28% and -102.29%.
| Gross Margin | 67.52% |
| Operating Margin | -95.28% |
| Pretax Margin | -98.85% |
| Profit Margin | -102.29% |
| EBITDA Margin | -93.57% |
| EBIT Margin | -95.28% |
| FCF Margin | n/a |
Dividends & Yields
SOPHiA GENETICS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.21% |
| Shareholder Yield | -2.21% |
| Earnings Yield | -25.64% |
| FCF Yield | -12.67% |
Analyst Forecast
The average price target for SOPHiA GENETICS is $7.00, which is 62.41% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.00 |
| Price Target Difference | 62.41% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 20.92% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SOPHiA GENETICS has an Altman Z-Score of -3.46 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.46 |
| Piotroski F-Score | 2 |
